Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 20, 2020

View Archived Issues

Nanoparticle fights pancreatic cancer's chemo resistance

FLUVID influenza-COVID-19 therapeutic cocktail demonstrates effective antiviral activity

Lumasiran approved in the E.U. for the treatment of PH1

First patient dosed in phase I study of SEFA-1024

Black Swan Pharmaceuticals patents antisense oligonucleotides targeting SOD1

New CD73 inhibitors discovered at Abbisko Therapeutics

Sotatercept for RV-PA coupling and RV function improvement in PAH

Sichuan Kelun-Biotech Biopharmaceutical identifies new STING agonists

New HBsAg and HBeAg secretion inhibitors discovered at Nanjing Hepo Pharmaceuticals

Jiangsu Carefree Pharmaceutical synthesizes new tyrosine kinase receptors inhibitors

Promore reports phase IIb data on ropocamptide for venous leg ulcers

Promising preclinical data for AK-119 as potential immunotherapy for COVID-19

Investigators plant better AID for protein degradation

Nourin-dependent miR-137 as early diagnostic biomarker for unstable angina

Phase III RATIONALE 303 trial of tislelizumab in NSCLC meets primary endpoint at interim analysis

IL-2-antibody fusion shows promising effects in metastatic melanoma and breast cancer murine models

FDA issues EUA for baricitinib with remdesivir for hospitalized COVID-19 patients

AVO-101: promising results for weight loss and NASH reduction

New trial evaluates F4 Pharma's FX-06 in patients with severe COVID-19

Novel mouse model allows efficacy evaluation of checkpoint inhibitors targeting CD28

Enrollment begins in registrational trial of Nyxol to reverse pharmacologically induced mydriasis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...